For all antigens, may count evidence any of the following: evidence of the antigen or documented history of the illness or a seropositive test result. For combination vaccinations that require more than one antigen (i.e., MMR), must find evidence of all three antigens.

MMR: A second dose of MMR by the member's 13th birthday. A member is considered compliant if they have received either:

• one MMR on or between the member's 4th and 13th birthdays or
• two MMRs on or between the member's 1st and 4th birthdays.

Hepatitis B: Three hepatitis B with with different dates of service on or before the member's 13th birthday. May count as if patient received the complete two-dose hepatitis B regimen, or if they have received one dose of the two-dose regimen and two other doses of hepatitis B.

In 2004, HEDIS showed commercial plans achieving 63.0% and Medicaid plans achieving 57.3%.

For updated national statistics see: http://www.cdc.gov/nip/data/default.htm
and: http://www.cdc.gov/nip/coverage/default.htm

Health Disparity Prevetnion Collaborative has target goal of >90%
http://healthdisparities.net/hdc/html/collaboratives.topics.prevention.asp (#5b)

Programs directed at vaccine preventable diseases are critical.

Of the estimated 125,000 new cases of hepatitis B each year, more than 70 percent affect adolescents
and young adults. Hepatitis B is highly infectious and sometimes results in liver failure and death. Currently there are about 1.25 million people who have life-long hepatitis B virus infection. Each year about 4,000-5,000 of these people die from related liver disease resulting in over $700 million of medical and work-loss costs. Approximately 25% of children who become infected with life-long hepatitis B virus would be expected to die of related liver disease as adults.
If the measles vaccine was discontinued in the United States, 3-4 million measles cases would occur annually and result in more than 1,800 deaths, 1,000 cases of encephalitis, and 80,000 cases of pneumonia. Immunizations are one of the most cost-effective health intervention strategies available, saving society more than $5 for each dollar spent. The MMR vaccine saves $16.34 in direct medical costs for every $1 spent. The expected measles morbidity among a birth cohort of 4.1 million without vaccination against measles would be 3.7 million cases, over 350,000 complications, and 1,859 deaths, with total direct and indirect costs of $2.2 billion and $1.6 billion, respectively.
If vaccination for chicken pox were to stop, the disease would quickly return to its previous high rate of infection, and every child would miss a week of school, every parent a week of work, and 50-100 varicella-related deaths would occur each year, most of them in previously healthy children and adults.

Adolescent immunizations for hepatitis B, varicella (chickenpox), and MMR (measles, mumps, rubella) are recommended by the Centers for Disease Control and Prevention. The adolescent schedule is published as part of the childhood schedule; see: http://www.cdc.gov/nip/recs/child-schedule.htm
For Measure, see http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=448
This measure is also in the Health Disparities Collaborative, Prevention Pilot, Measure #5b http://healthdisparities.net/hdc/html/collaboratives.topics.prevention.asp

Many adolescents continue to be affected by these vaccine-preventable diseases, in part because vaccination programs have not focused on improving vaccination coverage among adolescents. Safe and effective vaccines are available; immunizations successfully and inexpensively reduce the incidence of these dangerous and costly diseases.

The measures indicates health centers competence and diligence regarding accepeted preventative measures intended to reduce premature morbidity and mortality. Analysis of measure requires addressing screening, reminder, recall and follow-up, adherence to practice guidelines, patient and provider education.

Note that although this measure is directed towards, MMR & HepB, the complete series for adolescent should include receipt of Varicella Zoster (Chickenpox) vaccine and the Td (tetanus) booster; see: http://www.ncqa.org/Docs/SOHCQ_2005.pdf (p. 23)
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=7441
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=449